| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 21,320 | 25,025 | 24,815 | 15,540 | | Cost of Revenue | 4,962 | 4,656 | 4,039 | 5,459 | | | Gross Profit | 16,358 | 20,369 | 20,776 | 10,081 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,000 | 5,391 | 1,819 | 3,017 | | Non Recurring |
-
|
-
|
-
| 484,112 | | Others | 7,559 | 9,247 | 10,451 | 23,390 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,799 | 5,731 | 8,506 | (500,438) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (110) | (61) | 95 | 439 | | Earnings Before Interest And Taxes | 5,689 | 5,670 | 8,601 | (499,999) | | Interest Expense | 6,801 | 6,789 | 6,338 | 6,996 | | Income Before Tax | (1,112) | (1,119) | 2,263 | (506,995) | | Income Tax Expense | 335 | (311) | (24) | (49,456) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (955) | (925) | 2,404 | (457,534) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (955) | (925) | 2,404 | (457,534) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($955) | ($925) | $2,404 | ($457,534) |
|
0.51% Nasdaq 
Income Statement
